MyFinsight
Home
Blog
About
Contact
Download
Download image
Diagnostics
$2,463M
(4.23%↑ Y/Y)
Biotechnology Segment
$1,798M
(8.77%↑ Y/Y)
Life Sciences
$1,792M
(0.56%↑ Y/Y)
Sales
$6,053M
(4.40%↑ Y/Y)
Gross profit
$3,523M
(3.59%↑ Y/Y)
Cost of sales
$2,530M
(5.55%↑ Y/Y)
Operating profit
$1,154M
(20.46%↑ Y/Y)
Interest income
$3M
(-25.00%↓ Y/Y)
Selling, general and
administrative expenses
$1,991M
(-3.35%↓ Y/Y)
Research and development
expenses
$378M
(-1.31%↓ Y/Y)
Earnings before income
taxes
$1,076M
(10.13%↑ Y/Y)
Interest expense
$67M
(-22.99%↓ Y/Y)
Other income
(expense), net
-$14M
(-113.73%↓ Y/Y)
Net earnings
$908M
(11.00%↑ Y/Y)
Income taxes
$168M
(5.66%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
logo (3)-svg
DHR
logo (3)-svg
DHR